Back
Eagle Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Sell
14
EGRX
Eagle Pharmaceuticals
Last Price:
0.90
Seasonality Move:
-5.96%
Sell
39
LLY
Eli Lilly and
Last Price:
749.91
Seasonality Move:
3.67%
Sell
14
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.65. The Score for EGRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $753.41. The Score for LLY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.65
The current trend is relatively stagnant and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $753.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 40.32 | Sell |
| Chaikin Money Flow: | -2942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.84) | Sell |
| Bollinger Bands (100): | (1.36 - 5.36) | Sell |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -37.99 | Sell |
| Relative Strength Index (14 RSI): | 33 | Sell |
| Chaikin Money Flow: | 3266793 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (773.88 - 894.52) | Sell |
| Bollinger Bands (100): | (825.42 - 941.78) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 4.12 | Sell |
| 8-day EMA: | 0.73 | Sell |
| 20-day EMA: | 0.83 | Sell |
| 50-day EMA: | 1.63 | Sell |
| 200-day EMA: | 4.82 | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 775.74 | Sell |
| 20-day SMA: | 815.11 | Sell |
| 50-day SMA: | 872.24 | Sell |
| 200-day SMA: | 834.58 | Sell |
| 8-day EMA: | 766.92 | Sell |
| 20-day EMA: | 806.67 | Sell |
| 50-day EMA: | 849.91 | Sell |
| 200-day EMA: | 812.36 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.45 per share.
Eagle Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||